4D Molecular Therapeutics Inc logo

4D Molecular Therapeutics Inc

$ 21.52 -0.29 (-1.33%) 10:08 PM EST
P/E:
At Loss
P/B:
2.77
Market Cap:
$ 697.08M
Enterprise V:
$ 495.31M
Volume:
275.76K
Avg Vol (2M):
600.01K
Volume:
275.76K
Market Cap $:
697.08M
PE Ratio:
At Loss
Avg Vol (2-Month):
600.01K
Enterprise Value $:
495.31M
PB Ratio:
2.77

Business Description

Description
4D Molecular Therapeutics Inc a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built portfolio of gene therapy product candidates focused in three therapeutic areas: ophthalmology (intravitreal vector), cardiology (intravenous vector) and pulmonology (aerosol vector). It has three product candidates in clinical trials: 4D-125 for the treatment of X-linked retinitis pigmentosa in a Phase 1/2 clinical trial, 4D-110 for the treatment of choroideremia in a Phase 1 clinical trial, and 4D-310 for the treatment of Fabry disease in a Phase 1/2 clinical trial. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration, and 4D-710 for the treatment of cystic fibrosis lung disease.
Name Current Vs Industry Vs History
Cash-To-Debt 13.76
Equity-to-Asset 0.9
Debt-to-Equity 0.07
Debt-to-EBITDA -0.16
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 13.03
Distress
Grey
Safe
Beneish M-Score -6.53
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 39.36
9-Day RSI 56.75
14-Day RSI 63.65
6-1 Month Momentum % 6.67
12-1 Month Momentum % -64.82

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.14
Quick Ratio 17.14
Cash Ratio 16.79
Days Sales Outstanding 126.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -37.1

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -5376.43
Net Margin % -5331.88
ROE % -38.58
ROA % -35.02
ROIC % -140.51
ROC (Joel Greenblatt) % -376.66
ROCE % -36.98